BCIQ Profiles

Company Profile ReportTarget Profile Report

Juno licenses gamma secretase inhibitor, related IP

Juno Therapeutics Inc. (NASDAQ:JUNO) announced on Wednesday a trio of licensing agreements to advance its multiple myeloma (MM) program combining gamma secretase inhibitors

Read the full 231 word article

How to gain access

Continue reading with a
two-week free trial.